Jyothy Labs Ltd - 532926 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio recording of the conference call for the quarter and nine months ended December 31, 202225-01-2023
25-01-2023
Jyothy Labs posts 76% increase in consolidated net profit
Total income grew 15.6 per cent to 627 crore25-01-2023
Jyothy Labs Ltd - 532926 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201525-01-2023
Q3FY23 Quarterly Result Announced for Jyothy Labs Ltd.
Personal products manufacturer Jyothy Labs announced Q3FY23 results: Q3FY23: Net Sales at Rs 613 crore, increased by 13.7%. EBITDA margin at Rs 84.4 crore (13.8% of Net sales), increased by 37.9%. Net Profit at Rs 67.4 crore, increased by 77.2%. Commenting on the financial performance of Q3FY2023, Ms. M R Jyothy, Managing Director, Jyothy Labs Limited said “We continue to drive execution led growth to build scale. This will deliver vatue for all the stakeholders. Consistent market share gains builds a stronger operating environment which further drives future growth opportunities. We have been witnessing a good traction for all our product categories and are determined to achieve consistent growth momentum for future.” Result PDF25-01-2023
Jyothy Labs Ltd - 532926 - Announcement under Regulation 30 (LODR)-Investor Presentation
Presentation on the Company's performance for the quarter and nine months ended December 31, 2022.25-01-2023
Jyothy Labs Ltd - 532926 - Results For The Quarter And Nine Months Ended December 31, 2022
The Board approved the Un-audited Financial Results on Standalone and Consolidated basis for the quarter and nine months ended December 31, 2022 with Limited Review by the Statutory Auditors of the Company25-01-2023
Jyothy Labs Ltd - 532926 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201523-01-2023
Jyothy Labs Ltd - 532926 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
The Company is organizing a conference call for analyst/ investors on Wednesday, January 25, 2023 at 16.30 hours IST, subsequent to declaration of its Un-audited Financial Results for the quarter and nine months ended December 31, 2022 to discuss the Company's financial performance for the said period and the way forward17-01-2023
Jyothy Labs Ltd - 532926 - Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On Wednesday, January 25, 2023
Jyothy Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/01/2023 ,inter alia, to consider and approve Meeting of the Board of Directors of Jyothy Labs Limited is scheduled to be held on Wednesday, January 25, 2023, inter-alia to consider and approve the Un-audited Financial Results of the Company on Standalone and Consolidated basis for the quarter and nine months ended December 31, 2022, with limited review thereon by the Statutory Auditors of the Company17-01-2023
Jyothy Labs Ltd - 532926 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of Newspaper Advertisement issued pursuant to the Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016 and Sample Reminder Letter sent to shareholders12-01-2023